United Kingdom Diabetic Foot Ulcer Treatment Market By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region, Competition, Forecast and Opportunities 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited Kingdom Diabetic Foot Ulcer Treatment Market By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others), By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers), By End User (Hospitals & Clinics, Ambulatory Care Centers, and Others), By Region, Competition, Forecast and Opportunities 2028
Diabetic foot ulcer is an open sore or wound that occurs in approximately 15 percent of people suffering from diabetes mellitus. Ulcers can be formed due to combination of factors such as poor blood circulation, foot deformities, irritation, and prolonged existence of diabetes. Diabetic foot ulcer can be broadly categorized into five categories namely neuropathic ulcers, ischemic ulcers, neuro-ischemic ulcers, infectious ulcers, and traumatic ulcers. Diabetic peripheral neuropathy is a precipitating factor in almost 90% of diabetic foot ulcers. Some of the common medical approaches which are applicable in prevention of diabetic foot ulcers include cleaning the wound with mild antiseptic solution, applying antibiotics for infection management, controlling blood sugar level, undergoing advanced wound therapies, and surgical interventions. Amoxicillin-clavulanate, Ciprofloxacin, and Clindamycin are some of the regular antibiotics which are prescribed by healthcare professional for prevention of diabetic foot ulcer infections. In United Kingdom, approximately 6000 diabetics undergo amputations of leg, toe, or foot every year and up to 80 percent of people die within 5 years after amputation. However, increase in preference for platelet-rich plasma or platelet-rich fibrin among healthcare professionals in UK are emerging as possible treatment options for nonhealing ulcers which have thereby reduced the requirement for amputations. Increasing prevalence of diabetes being a primary cause of diabetic foot ulcer mainly among population of Scotland, England, Wales, and Northern Ireland are expected to propel the growth of United Kingdom diabetic foot ulcer treatment market in the forecast period. Moreover, growing geriatric population in the region coupled with high instances of diabetic foot ulcers are also expected to register an impressive growth to the market in forecast period. Age-related factors such as poor wound healing and reduced blood circulation are primarily leading to the development of ulcers in elder people. Growing technological advancements in healthcare system of United Kingdom which mainly focuses on early curing of diabetic foot ulcer is also a significant factor behind lucrative growth of United Kingdom diabetic foot ulcer treatment market.
Growing Prevalence of Diabetes
According to the report published by Patient UK in 2021, it has been observed that around 4-12% of people above 55-70 years of age get diagnosed with PAD every year. Moreover, 500-1,000 new cases of critical limb ischemia are reported in United Kingdom yearly.
Increase in Geriatric Population
According to the analysis presented by Statista on ‘The Aging Population of England and Wales’ in 2022, it has been observed that around 14% of the total population in the countries were aged between 50-59 years of age, followed by 11% of people between 60-69 years of age, 8% of people were aged between 70-79 years of age, and so on.
Download Free Sample ReportTechnological Advancements
Growing advancements in treatment procedures such as advanced wound care products, remote monitoring, negative pressure wound therapy (NPWT), and hyperbaric oxygen therapy (HBOT) are one of the emerging significant factors which are leading to the growth of United Kingdom diabetic foot ulcer treatment market in the forecast period. NPWT involves the application of a vacuum dressing to the wound site, which helps to promote healing by removing excess fluid, increasing blood flow, and stimulating tissue growth. This therapy has shown promising results in treating diabetic foot ulcers and reducing the need for amputation. Modern development of new bandage treatment known as a scaffold have evolved as an effective prevention for diabetic foot ulcers. 3D bio printed scaffolds slowly release antibiotics over 4 weeks to effectively heal wounds. Moreover, Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) approved by U.S. Food and Drug Administration have been a recent addition made to healthcare system for treatment of diabetic foot ulcers.
Recent Developments
- In October2022, Healthium Medtech introduced the Theruptor Novo wound dressing portfoliofor the treatment of chronic wounds, including diabetic foot ulcers. Thisstrategy has enabled the company to expand its offering of advanced wound careproducts and meet the growing demand for wound care products.
- In January2022, Smith+Nephew received FDA approval on PICO 7 and PICO 14 DisposableNegative Pressure Wound Therapy for the treatment of Class I and II wounds,including traumatic, subacute wounds, burns and diabetic foot ulcers. Thisstrategy has allowed the company to expand the reach of its products to a largecustomer base.
- In July 2018,Mölnlycke acquired the German wound care company SastoMed GmbH. The aim is toexpand product offerings to help patients and healthcare professionalsaccelerate the wound healing process and treatment of chronic wounds such asdiabetic foot ulcers.
United Kingdom diabetic foot ulcer treatment market is segmented based on treatment, ulcer type, end user, company, and region. In terms of treatment, the diabetic foot ulcer treatment market is categorized into wound care dressings, biologics, therapy devices, antibiotic medications, and others. Based on ulcer type, the United Kingdom diabetic foot ulcer treatment market is divided into neuropathic ulcers, ischemic ulcers, and neuroischemic ulcers. Based on end user, diabetic foot ulcer treatment market is fragmented into hospitals & clinics, ambulatory care centers, and others. Based on region, the market is segmented into
Market Players
Medtronic Ltd., 3M United Kingdom Public Limited, ConvaTec, Inc., Coloplast Ltd., Smith & Nephew plc., B. Braun Medical Ltd., Medline Industries Ltd., and Mölnlycke Health Care Limited are some of the key players in the United Kingdom diabetic foot ulcer treatment market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2018 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in tons, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Treatment Ulcer Type End User |
| Regional Scope | London, East Anglia, Southwest, Southeast, Scotland, East Midlands, Yorkshire & Humberside |
| Key Companies Profiled | Medtronic Ltd., 3m United Kingdom Public Limited, ConvaTec, Inc., Coloplast Ltd., Smith & Nephew plc., B. Braun Medical Ltd., Medline Industries Ltd., Mölnlycke Health Care Limited |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy